Recent advances in the biology of n-6 fatty acids

Nutrition

Volumn 13, Issue 11-12, 1997, Pages 978-985

  Galli, Claudio ^a   Marangoni, Franca ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Anandamide; Cell function; Cholesterol lowering; Cytochrome p450 metabolites; Iso prostanes; Lactation; N 6 fatty acids; Peroxisomal oxidation; Recommended intakes

Indexed keywords

ANANDAMIDE; CYTOCHROME P450; OMEGA 6 FATTY ACID;

ARACHIDONIC ACID METABOLISM; CELL FUNCTION; CHEMICAL MODIFICATION; CHOLESTEROL METABOLISM; ENZYME METABOLISM; FATTY ACID OXIDATION; FOOD INTAKE; LACTATION; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW;

ADULT; ARACHIDONIC ACIDS; CYTOCHROME P-450 ENZYME SYSTEM; DIETARY FATS, UNSATURATED; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; HUMANS; INFANT; LIPIDS;

EID: 0031474949     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(97)00341-9     Document Type: Review

References (87)

1. Sprecher H, Luthria DL, Mohammed BS, et al. Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids. J Lipid Res 1995;36:2471
2. Mohammed BS, Sankarappa S, Geiger M, et al. Reevaluation of the pathway for the metabolism of 7,10,13,16-docosatetraenoic acid to 4,7,10,13,16 docosapentaenoic acid in rat liver. Arch Biochem Biophys 1995;317:179
3. Voss A, Reinhart M, Sankarappa S, et al. The metabolism of 7,10,13,16-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J Biol Chem 1991;26:19995
4. Coniglio JG, Buch D, Grogan WM Jr. Effect of eicosa-5,8,11,14-tetraynoic acid on fatty acid composition of selected organs in the rat. Lipids 1975;11:143
5. Galli C, Agradi E, Paoletti R. The (n-6) pentaene: (n-3) hexaene fatty acid ratio as an index of linolenic acid deficiency. Biochim Biophys Acta 1974;369:142
6. Caruso D, Risé P, Galella G, et al. Formation of 22 and 24 carbon 6-desaturated fatty acids from exogenous deuterated arachidonic acid is activated in THP-1 cells at high substrate concentrations. FEBS Lett 1994;343:195
7. Gordon JA, Heller SK, Kaduce TL, et al. Formation and release of a peroxisome dependent arachidonic acid metabolite by human skin fibroblasts. J Biol Chem 1994;369:4103
8. Cunnane SC, Ryan MA, Craig KS, et al. Synthesis of linoleate and alpha-linolenate by chain elongation in the rat. Lipids 1995;30:781
9. Oliw EH. Oxygenation of polyunsaturated fatty acids by cytochrome p450 monoxygenase. Prog Lipid Res 1994;33:329
10. Oyekan AO. Role of the cytochrome p450 enzyme system as a humoral modulator of vasomotor responses in rat renal vasculature. J Cardiovasc Pharmacol 1994;24:238
11. Escalante B, Erlij D, Falck JR, et al. Cytochrome p450-dependent arachidonate metabolites affect renal transport in the rabbit. J Cardiovasc Pharmacol 1993;22:S106
12. 2+ entry in human and bovine endothelial cells. J Physiol (Lond) 1995;482:259
13. Hecker M, Bara AT, Bauersachs J, et al. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome p450-derived arachidonic acid metabolite in mammals. J Physiol (Lond) 1994;481:407
14. Campbell WB, Gebremedhin D, Pratt PF, et al. Identification of epoxy-eicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996;78:415
15. Makita K, Takahashi K, Karara A, et al. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome p450 epoxygenase induce hypertension in rats fed a high salt diet. J Clin Invest 1994;94:2414
16. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915
17. Morrow JD, Harris TM, Roberts LJ, II. Non cyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for the measurements of eicosanoids. Anal Biochem 1990;184:1
18. Morrow JD, Hill KE, Burk RF, et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990;87:9383
19. 2-isoprostanes) in smokers-Smoking as a cause of oxidative damage. New Engl J Med 1995;332:1198
20. 2-isoprostane receptor on rat vascular smooth muscle cells. Am J Physiol 1993;364:C1619
21. Di Marzo V, De Petrocellis L, Sepe N, et al. Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells. Biochem J 1996;316:977
22. Cadas H, Gaillet S, Beltramo M, et al. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J Neurosci 1996;16:3934
23. Wenger T, Toth BE, Martin BR. Effects of anandamide (endogen cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats. Life Sci 1995;56:2057
24. Wiley J, Balster R, Martin B. Discriminative stimulus effects of anandamide in rats. Eur J Pharmacol 1995;276:49
25. Smith PB, Compton DR, Welch SP, et al. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 1994;270:219
26. Terranova JP, Michaud JC, Le Fur G, et al. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedebergs Arch Pharmacol 1995;352:576
27. Cabral GA, Toney DM, Fischer-Stenger K, et al. Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells. Life Sci 1995;56:2065
28. Lee M, Yang KH, Kaminski NE. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J Pharmacol Exp Ther 1995;275:529
29. Varga K, Lake K, Martin BR, et al. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 1995;278:279
30. De Petrocellis L, Orlando P, Di Marzo V. Anandamide, an endogenous cannabinomimetic substance, modulates rat brain protein kinase C in vitro. Biochem Mol Biol Intern 1995;36:1127
31. Wartmann M, Campbell D, Subramanian A, et al. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett 1933;359:133
32. Emken EA, Adlof RO, Gulley RM. Dietary linoleic acid influences desaturation and acylation of deuterium labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta 1994;1213:277
33. Emken EA, Adlof RO, Rakoff H, et al. Human metabolic studies with deuterated alpha linolenic acid. Nutrition 1992;8:213
34. Carnielli VP, Wattimena DJL, Luijendijk IHT, et al. The very low birth weight premature infant is capable of synthesizing arachidonic acid and docosa-hexaenoic acids from linoleic and linolenic acids. Pediatr Res 1996;40:169
35. Demmelmair H, Schenck U, Behrendt E, et al. Estimation of arachidonic acid synthesis in full term neonates using natural variation of 13C content. Pediatr Gastroenterol Nutr 1995;21:31
36. Sauerwald TU, Hachey DL, Jensen CJ, et al. Effect of dietary α-linolenic acid on incorporation of docosahexaenoic and arachidonic acids into plasma phospholipids of term infants. Lipids 1996;S131
37. Yang J, Chen ZY, Cunnane SC. Application of the balance method to determining accumulation, metabolism, and apparent oxidation of linoleic and alpha-linolenic acids in the pregnant rat. Metab Clin Exp 1994;43:940
38. Sanders TA, Roshanai F. Platelet phospholipid fatty acid composition and function in vegans compared with age- and sex-matched omnivore controls. Eur J Clin Nutr 1992;46:823
39. Phinney SD, Odin RS, Johnson SB, et al. Reduced arachidonate in serum phospholipids and cholesterol esters associated with vegetarian diet in humans. Am J Clin Nutr 1990;51:385
40. Sanders TA, Ellis FR, Dickerson JW. Studies of vegans: the fatty acid composition of plasma choline phosphoglycerides, erythrocytes, adipose tissue, and breast milk, and some indicators of susceptibility to ischemic heart disease in vegans and omnivore controls. Am J Clin Nutr 1978;31:805
41. Agren JJ, Törmälä ML, Nenonen MT, et al. Fatty acid composition of erythrocyte, platelet and serum lipids in strict vegans. Lipids 1995;30:365
42. Pauletto P, Puato M, Caroli MG, et al. Lower blood pressure and atherogenic lipoprotein levels in a population living on a freshwater fish diet versus a population living on a vegetarian diet, in Tanzania, the Lugaawa study. Lancet 1996;348:784
43. Mann NJ, Johnson LG, Warrick GE, et al. The arachidonic acid content of the Australian diet is lower than previously estimated. J Nutr 1995;125:2528
44. Nelson GJ, Kelley DS, Emken EA, et al. A human arachidonic acid feeding study conducted in a metabolic research unit: the study design. Lipids 1997;32:415
45. Uauy R, Peirano P, Hoffman D, et al. Role of essential fatty acids in the function of the developing nervous system. In: Salem N, Simopoulos AP, Galli C, Lagarde M, Knapp HR, eds. Fatty acids and lipids from cell biology to human disease. Lipids 1996;31:S-167
46. Koletzko B, Thiel I, Abiodun PO. The fatty acid composition of human milk in Europe and Africa. J Pediatr 1992;120:562
47. Makrides M, Simmer K, Neumann M, et al. Changes in the polyunsaturated fatty acids of breast milk from mothers of full term infants over 30 weeks of lactation. Am J Clin Nutr 1995;51:1231
48. Agostoni C. Trojan S, Bellu R, et al. Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain poly-unsaturated fatty acids. Pediatr Res 1995;38:262
49. Makrides M, Neumann M, Simmer K, et al. Are long-chain polyunsaturated fatty acid essential nutrients in infancy? Lancet 1995;345:1463
50. Carlson SE. Werkman SH, Talley EA. Effect of long chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without pulmonary dysplasia. Am J Clin Nutr 1996;63:687
51. Hegsted DM, Ausman LM, Johnson JA, et al. Dietary fat and serum lipids: an evaluation of the experimental data. Am J Clin Nutr 1993;57:875
52. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta analysis of 27 trials. Arterioscler Thromb 1992;12:911
53. Gardner CD, Kraemer HC. Monounsaturated versus polyunsaturated dietary fat and serum lipids. A meta-analysis. Arterioscler Thromb Vasc Biol 1995;15:1917
54. Ma J, Folsom AR, Shahar E, et al. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The atherosclerosis risk in communities (ARIC) study investigators. Am J Clin Nutr 1995;62:564
55. Mize CE, Uauy R, Kramer R, et al. Lipoprotein-cholesterol response in healthy infants fed defined diets from ages 1 to 12 months: comparison of diets predominant in oleic acid versus linoleic acid, with parallel observations in infants fed a human milk-based diet. J Lipid Res 1995;36:1178
56. Evans AE, Bingham A, Patterson JB, et al. Autres pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse. Q J Med 1995;88:469
57. Renaud S, de Lorgeril M, Delaye J, et al. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr 1995;61(suppl 6):1360
58. Simon JA, Hodgkins ML, Browner WS, et al. Serum fatty acids and the risk of coronary heart disease. Am J Epidemiol 1995;142:469
59. McLennan PL. Bride TM, Abeywardena MY, et al. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am Heart J 1992;123:1555
60. McLennan PL, Bridle TM, Abeywardena MY, et al. Comparative efficacy of n-3 and n-6 polyunsaturated fatty acids in modulating ventricular fibrillation threshold in marmoset monkeys. Am J Clin Nutr 1993;58:666
61. Kang JX, Leaf A. Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 1994;91:9886
62. + channels by directly binding to the channel proteins. Proc Natl Acad Sci USA 1996;93:3542
63. Borkman M, Storlien LH, Pan DA, et al. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 1993;328:238
64. Yagaloff KA, Franco L, Simko B, et al. Essential fatty acids are antagonists of the leukotriene B4 receptor. Prostaglandins Leukotrien Essent Fatty Acids 1995;52:293
65. Clarke SD, Jump DB. Polyunsaturated fatty acid regulation of hepatic gene transcription. In: Salem N, Simopoulos AP, Galli C, Lagarde M, Knapp HR, eds. Fatty acids and lipids from cell biology to human disease. Lipids 1996;31:S7
66. Katsurada A, Iretani N, Fukuda H, et al. Effects of nutrients and hormones on transcriptional and post-transcriptional regulation of acetyl CoA carboxylase in rat liver. Eur J Biochem 1990;190:435
67. Schwartz RS, Abraham S. Effect of dietary fat on the activity, content, rates of synthesis and degradation, and translation of mRNA coding malic enzyme. Arch Biochem Biophys 1983;221:206
68. Ntambi JM. Dietary regulation of stearoyl-CoA desaturase 1 gene expression in mouse liver. J Biol Chem 1991;267:10925
69. Clarke BA, Armstrong MK, Jump DB. Nutritional control of rat liver fatty acid synthase and S14 mRNA abundance. J Nutr 1990;120:218
70. Tebbey PW, McGowan KM, Stephens JM, et al. Arachidonic acid down regulates the insulin dependent glucose transporter gene (Glut 4) in 3T3-L1 adipocytes by inhibiting transcription and enhancing mRNA turnover. J Biol Chem 1994;269:639
71. Tebbey PW, Buttke TM. Stearoyl-CoA desaturase gene expression in lymphocytes. Biochem Biophys Res Commun 1992;186:531
72. Amri EZ, Bonino F, Ailhaud G, et al. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. J Biol Chem 1995;270:2367
73. Sellmayer A, Danesch U, Weber PC. Effects of different polyunsaturated fatty acids on growth-related early gene expression and cell growth. In: Salem N, Simopoulos AP, Galli C, Lagarde M, Knapp HR. eds. Fatty acids and lipids from cell biology to human disease. Lipids 1996;31:837
74. Clarke SD, Jump DB. Dietary polyunsaturated fatty acid regulation of gene transcription. Annu Rev Nutr 1994;14:83
75. Keller H, Deyer C, Medin J, et al. Fatty acids and retinoids control lipid metabolism through activation of Peroxisome Proliferator-Activated Receptor-Retinoid X Receptor Heterodimers. Proc Natl Acad Sci USA 1993;90:2160
76. Tontonoz P, HU E, Graves RA, et al. mPPARg2: Tissue specific regulator of an adipocyte enhancer. Genes Dev 1994;8:1224
77. Gottlicher M, Widmark E, Li Q, et al. Fatty acids activate chimera of the clofibric acid activated receptor and glucocorticoid receptor. Proc Natl Acad Sci USA 1992;89:4653
78. Ren B, Thelen A, Jump D. Peroxisome proliferator-activated receptor a inhibits hepatic S14 gene transcription. Evidence against the peroxisome proliferator-activated receptor a as the mediator of polyunsaturated fatty acid regulation of S14 gene transcription. J Biol Chem 1996;271:17167
79. Miller CW, Ntambi JM. Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. Proc Natl Acad Sci USA 1996;93:9443
80. Grimm H, Tibell A, Norrlind B, et al. Nutrition and allorejection impact of lipids. Transpl Immunol 1995;3:62
81. Friedman A, Sklan D. Effect of dietary fatty acids on antibody production and fatty acid composition of lymphoid organs in broiler chicks. Poult Sci 1995;74:1463
82. Rasmussen LB, Kiens B, Pedersen BK, et al. Effect of diet and plasma fatty acid composition on immune status in elderly men. Am J Clin Nutr 1994;59:572
83. Fats and oils in human nutrition. Report of a joint expert consultation. FAO Food and Nutrition Paper 57, 1994
84. Gavino GR, Gavino VC. Rat liver outer mitochondrial carnitine palmitoyl transferase activity towards long chain polyunsaturated fatty acids and their CoA esters. Lipids 1991;26:266
85. Leyton J, Drury PJ, Crawford MA. Differential oxidation of saturated and unsaturated fatty acids in vivo in the rat. Br J Nutr 1987;57:383
86. Jones PJ. Dietary linoleic, alpha-linolenic and oleic acids are oxidized at similar rates in rats fed a diet containing these fatty acids in equal proportions. Lipids 1994;29:491
87. Galli C, Sirtori CR, Mosconi C, et al. Prolonged retention of doubly labeled phosphatidylcholine in human plasma and erythrocytes after oral administration in man. Lipids 1992;12:1005